Prescrire ("to prescribe" in French) is an international medical journal, which uses evidence based science to make recommendations on drugs. It is written by health care professionals for health care professionals, but it is unique in that it does not accept any pharmaceutical monies for advertising or for payment to reviewers. This journal makes money by having 33,500 subscribers---medical professionals who turn to this journal for unbiased information. This is a completely independent journal---they have signed a "Non, Merci" (no, thank you) charter to maintain no conflicts of interest.
Here is Prescrire's recent publications on Tysabri, Lemtrada and Aubagio from their March issue:
http://ccsviinms.blogspot.com/2015/04/i ... -must.html
cheer